Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group
about
Oral acyclovir suppression and neurodevelopment after neonatal herpesImpact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infectionValacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Sexually transmitted infectionsGenital herpes: review of the epidemic and potential use of type-specific serologyRecent advances in management of genital herpes.Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled studyClinical Evidence: Genital herpesCan herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialPatient satisfaction with care for genital herpes: insights from a global survey.Genital herpes and its management.Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Sexual behaviour and condom use among individuals with a history of symptomatic genital herpesSuppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovirAn intravaginal ring for the simultaneous delivery of multiple drugs.
P2860
Q24615077-636574D8-5FCE-4415-BE2D-D8E3CA19D331Q24671668-3E3029CF-2226-45CB-8BFE-9465B76A1472Q30979930-911BC343-C43D-40CB-B7D6-EC01E8ED1A63Q33554048-6810F894-8D78-4CF6-8B6E-1BBD50972A38Q33790964-7980099E-DC2E-4370-8F8B-EDE14FAE2920Q33975387-2FF6279E-E6C2-416D-9DBA-C4BB45348F7BQ34012149-EE720A97-528D-4E28-BF61-81F32167C3EEQ34144914-F9864898-8F43-4BEE-A57D-9B31D9E42258Q34190888-294A8CEE-52DD-482F-BB1A-21A4FBF20E1AQ34408313-5A14922F-3191-4D0D-97A8-4DC4B404ED35Q35531277-6AB59947-F81E-4E1E-8C42-A85F9905768CQ35800206-BB21CD6A-0BB8-4778-B9DB-D46482E7627FQ36088773-90AAD76B-9C72-462A-AB54-503FC22BD53EQ36170672-BC0E6018-A9C8-419A-A1C4-2FA710AB4BDAQ36928526-8167CD90-5509-4C66-A184-67BB1ACEBD00Q37206230-43FC5048-5534-43EF-BFB6-FED66649A2E0Q37229605-84908C54-63E1-470A-AFFA-1DE00C44C01DQ37379716-3E408FDA-38C6-4C3D-AA20-99AE9E7A4074
P2860
Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@ast
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@en
type
label
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@ast
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@en
prefLabel
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@ast
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@en
P2093
P2860
P1476
Valaciclovir for the suppressi ...... l Valaciclovir HSV Study Group
@en
P2093
Bodsworth NJ
Robinson J
Vejlsgaard G
P2860
P304
P577
1997-04-01T00:00:00Z